Cargando…
Piperazine-substituted derivatives of favipiravir for Nipah virus inhibition: What do in silico studies unravel?
Favipiravir is found to show excellent in-vitro inhibition activity against Nipah virus. To explore the structure–property relationship of Favipiravir, in silico designing of a series of piperazine substituted Favipiravir derivatives are attempted and computational screening has been done to evaluat...
Autores principales: | Lipin, Raju, Dhanabalan, Anantha Krishnan, Gunasekaran, Krishnasamy, Solomon, Rajadurai Vijay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799160/ https://www.ncbi.nlm.nih.gov/pubmed/33458565 http://dx.doi.org/10.1007/s42452-020-04051-9 |
Ejemplares similares
-
Favipiravir (T-705) protects against Nipah virus infection in the hamster model
por: Dawes, Brian E., et al.
Publicado: (2018) -
Evaluation of action of steroid molecules on SARS-CoV-2 by inhibiting NSP-15, an endoribonuclease
por: Dhanabalan, Anantha Krishnan, et al.
Publicado: (2022) -
Substituted Piperazines as Novel Potential Radioprotective Agents
por: Filipova, Alzbeta, et al.
Publicado: (2020) -
De Novo Assembly of Highly Substituted Morpholines
and Piperazines
por: Patil, Pravin, et al.
Publicado: (2017) -
Interaction between favipiravir and hydroxychloroquine and their combined drug assessment: in silico investigations
por: Parlak, Cemal, et al.
Publicado: (2021)